Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG

Abstract Background Interval duration measurements (IDMs) were compared between standard 12‐lead electrocardiograms (ECGs) and 6‐lead ECGs recorded with AliveCor's KardiaMobile 6L, a hand‐held mobile device designed for use by patients at home. Methods Electrocardiograms were recorded within, o...

Full description

Bibliographic Details
Main Authors: Robert Kleiman, Borje Darpo, Randy Brown, Todd Rudo, Svetlana Chamoun, David E. Albert, Johan Martijn Bos, Michael J. Ackerman
Format: Article
Language:English
Published: Wiley 2021-11-01
Series:Annals of Noninvasive Electrocardiology
Subjects:
Online Access:https://doi.org/10.1111/anec.12872
_version_ 1818931155333808128
author Robert Kleiman
Borje Darpo
Randy Brown
Todd Rudo
Svetlana Chamoun
David E. Albert
Johan Martijn Bos
Michael J. Ackerman
author_facet Robert Kleiman
Borje Darpo
Randy Brown
Todd Rudo
Svetlana Chamoun
David E. Albert
Johan Martijn Bos
Michael J. Ackerman
author_sort Robert Kleiman
collection DOAJ
description Abstract Background Interval duration measurements (IDMs) were compared between standard 12‐lead electrocardiograms (ECGs) and 6‐lead ECGs recorded with AliveCor's KardiaMobile 6L, a hand‐held mobile device designed for use by patients at home. Methods Electrocardiograms were recorded within, on average, 15 min from 705 patients in Mayo Clinic's Windland Smith Rice Genetic Heart Rhythm Clinic. Interpretable 12‐lead and 6‐lead recordings were available for 685 out of 705 (97%) eligible patients. The most common diagnosis was congenital long QT syndrome (LQTS, 343/685 [50%]), followed by unaffected relatives and patients (146/685 [21%]), and patients with other genetic heart diseases, including hypertrophic cardiomyopathy (36 [5.2%]), arrhythmogenic cardiomyopathy (23 [3.4%]), and idiopathic ventricular fibrillation (14 [2.0%]). IDMs were performed by a central ECG laboratory using lead II with a semi‐automated technique. Results Despite differences in patient position (supine for 12‐lead ECGs and sitting for 6‐lead ECGs), mean IDMs were comparable, with mean values for the 12‐lead and 6‐lead ECGs for QTcF, heart rate, PR, and QRS differing by 2.6 ms, −5.5 beats per minute, 1.0 and 1.2 ms, respectively. Despite a modest difference in heart rate, intervals were close enough to allow a detection of clinically meaningful abnormalities. Conclusions The 6‐lead hand‐held device is potentially useful for a clinical follow‐up of remote patients, and for a safety follow‐up of patients participating in clinical trials who cannot visit the investigational site. This technology may extend the use of 12‐lead ECG recordings during the current COVID‐19 pandemic as remote patient monitoring becomes more common in virtual or hybrid‐design clinical studies.
first_indexed 2024-12-20T04:12:06Z
format Article
id doaj.art-3912ef6d96c34b4aad920774d1089bf8
institution Directory Open Access Journal
issn 1082-720X
1542-474X
language English
last_indexed 2024-12-20T04:12:06Z
publishDate 2021-11-01
publisher Wiley
record_format Article
series Annals of Noninvasive Electrocardiology
spelling doaj.art-3912ef6d96c34b4aad920774d1089bf82022-12-21T19:53:53ZengWileyAnnals of Noninvasive Electrocardiology1082-720X1542-474X2021-11-01266n/an/a10.1111/anec.12872Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECGRobert Kleiman0Borje Darpo1Randy Brown2Todd Rudo3Svetlana Chamoun4David E. Albert5Johan Martijn Bos6Michael J. Ackerman7eResearch Technology Inc Philadelphia PA USAeResearch Technology Inc Philadelphia PA USAPPD Inc Wilmington NC USAeResearch Technology Inc Philadelphia PA USAeResearch Technology Inc Philadelphia PA USAAliveCor Corporation San Francisco CA USAWindland Smith Rice Comprehensive Sudden Cardiac Death Program Divisions of Heart Rhythm Services and Pediatric Cardiology Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology & Experimental Therapeutics Mayo Clinic Rochester MN USAWindland Smith Rice Comprehensive Sudden Cardiac Death Program Divisions of Heart Rhythm Services and Pediatric Cardiology Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology & Experimental Therapeutics Mayo Clinic Rochester MN USAAbstract Background Interval duration measurements (IDMs) were compared between standard 12‐lead electrocardiograms (ECGs) and 6‐lead ECGs recorded with AliveCor's KardiaMobile 6L, a hand‐held mobile device designed for use by patients at home. Methods Electrocardiograms were recorded within, on average, 15 min from 705 patients in Mayo Clinic's Windland Smith Rice Genetic Heart Rhythm Clinic. Interpretable 12‐lead and 6‐lead recordings were available for 685 out of 705 (97%) eligible patients. The most common diagnosis was congenital long QT syndrome (LQTS, 343/685 [50%]), followed by unaffected relatives and patients (146/685 [21%]), and patients with other genetic heart diseases, including hypertrophic cardiomyopathy (36 [5.2%]), arrhythmogenic cardiomyopathy (23 [3.4%]), and idiopathic ventricular fibrillation (14 [2.0%]). IDMs were performed by a central ECG laboratory using lead II with a semi‐automated technique. Results Despite differences in patient position (supine for 12‐lead ECGs and sitting for 6‐lead ECGs), mean IDMs were comparable, with mean values for the 12‐lead and 6‐lead ECGs for QTcF, heart rate, PR, and QRS differing by 2.6 ms, −5.5 beats per minute, 1.0 and 1.2 ms, respectively. Despite a modest difference in heart rate, intervals were close enough to allow a detection of clinically meaningful abnormalities. Conclusions The 6‐lead hand‐held device is potentially useful for a clinical follow‐up of remote patients, and for a safety follow‐up of patients participating in clinical trials who cannot visit the investigational site. This technology may extend the use of 12‐lead ECG recordings during the current COVID‐19 pandemic as remote patient monitoring becomes more common in virtual or hybrid‐design clinical studies.https://doi.org/10.1111/anec.12872Bland–Altmanclinical trialselectrocardiograminterval duration measurementsQTcremote monitoring
spellingShingle Robert Kleiman
Borje Darpo
Randy Brown
Todd Rudo
Svetlana Chamoun
David E. Albert
Johan Martijn Bos
Michael J. Ackerman
Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG
Annals of Noninvasive Electrocardiology
Bland–Altman
clinical trials
electrocardiogram
interval duration measurements
QTc
remote monitoring
title Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG
title_full Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG
title_fullStr Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG
title_full_unstemmed Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG
title_short Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6‐lead mobile ECG device and a standard 12‐lead ECG
title_sort comparison of electrocardiograms ecg waveforms and centralized ecg measurements between a simple 6 lead mobile ecg device and a standard 12 lead ecg
topic Bland–Altman
clinical trials
electrocardiogram
interval duration measurements
QTc
remote monitoring
url https://doi.org/10.1111/anec.12872
work_keys_str_mv AT robertkleiman comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg
AT borjedarpo comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg
AT randybrown comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg
AT toddrudo comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg
AT svetlanachamoun comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg
AT davidealbert comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg
AT johanmartijnbos comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg
AT michaeljackerman comparisonofelectrocardiogramsecgwaveformsandcentralizedecgmeasurementsbetweenasimple6leadmobileecgdeviceandastandard12leadecg